APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sertraline HCl

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sertraline HCl Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchSertraline HCl Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Sertraline HCl Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Sertraline HCl Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sertraline HCl Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Sertraline HCl Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Sertraline HCl market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sertraline HCl is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sertraline HCl is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sertraline HCl is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sertraline HCl is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sertraline HCl include Teva, Sun Pharmaceutical, Novartis, Mylan, Pfizer, Wockhardt, Unimarck Pharma India Pvt Ltd, Torrent Pharma and Tanabe Mitsubishi Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sertraline HCl market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sertraline HCl and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sertraline HCl sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sertraline HCl market size, projected growth trends, production technologies, key applications, and end-use industries.

Sertraline HCl Segment by Company

Teva

Sun Pharmaceutical

Novartis

Mylan

Pfizer

Wockhardt

Unimarck Pharma India Pvt Ltd

Torrent Pharma

Tanabe Mitsubishi Pharma

Lupin

Jing Xin Pharm

InvaGen

Genericon Pharma

G.L. Pharma

Daiichi-Sankyo

Aurobindo Pharma USA

Apotex

Alpic Biotech

Accord Healthcare

Sertraline HCl Segment by Type

20 mg

25 mg

50 mg

100 mg

Sertraline HCl Segment by Application

OCD

Premenstrual Anxiety Disorder

Panic Disorder

Depression

Other Indications

Sertraline HCl Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sertraline HCl market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sertraline HCl and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sertraline HCl.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sertraline HCl market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sertraline HCl manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sertraline HCl in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sertraline HCl in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sertraline HCl Industry Trends Table 2. Sertraline HCl Industry Drivers Table 3. Sertraline HCl Industry Opportunities and Challenges Table 4. Sertraline HCl Industry Restraints Table 5. Global Sertraline HCl Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sertraline HCl Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sertraline HCl Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Sertraline HCl Sales Market Share by Manufacturers Table 9. Global Sertraline HCl Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sertraline HCl Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sertraline HCl Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sertraline HCl Manufacturers, Product Type & Application Table 13. Global Sertraline HCl Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sertraline HCl by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 20 mg Table 17. Major Manufacturers of 25 mg Table 18. Major Manufacturers of 50 mg Table 19. Major Manufacturers of 100 mg Table 20. Global Sertraline HCl Sales by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Sertraline HCl Sales by Type (2021-2026) & (Units) Table 22. Global Sertraline HCl Sales by Type (2027-2032) & (Units) Table 23. Global Sertraline HCl Sales Market Share by Type (2021-2026) Table 24. Global Sertraline HCl Sales Market Share by Type (2027-2032) Table 25. Global Sertraline HCl Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 26. Global Sertraline HCl Revenue by Type (2021-2026) & (Units) Table 27. Global Sertraline HCl Revenue by Type (2027-2032) & (Units) Table 28. Global Sertraline HCl Revenue Market Share by Type (2021-2026) Table 29. Global Sertraline HCl Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of OCD Table 31. Major Manufacturers of Premenstrual Anxiety Disorder Table 32. Major Manufacturers of Panic Disorder Table 33. Major Manufacturers of Depression Table 34. Major Manufacturers of Other Indications Table 35. Global Sertraline HCl Sales by Application 2021 VS 2025 VS 2032 (Units) Table 36. Global Sertraline HCl Sales by Application (2021-2026) & (Units) Table 37. Global Sertraline HCl Sales by Application (2027-2032) & (Units) Table 38. Global Sertraline HCl Sales Market Share by Application (2021-2026) Table 39. Global Sertraline HCl Sales Market Share by Application (2027-2032) Table 40. Global Sertraline HCl Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 41. Global Sertraline HCl Revenue by Application (2021-2026) & (Units) Table 42. Global Sertraline HCl Revenue by Application (2027-2032) & (Units) Table 43. Global Sertraline HCl Revenue Market Share by Application (2021-2026) Table 44. Global Sertraline HCl Revenue Market Share by Application (2027-2032) Table 45. Global Sertraline HCl Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 46. Global Sertraline HCl Sales by Region (2021-2026) & (Units) Table 47. Global Sertraline HCl Sales Market Share by Region (2021-2026) Table 48. Global Sertraline HCl Sales Forecasted by Region (2027-2032) & (Units) Table 49. Global Sertraline HCl Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Sertraline HCl Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 51. North America Sertraline HCl Sales by Country (2021-2026) & (Units) Table 52. North America Sertraline HCl Sales by Country (2027-2032) & (Units) Table 53. Europe Sertraline HCl Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Europe Sertraline HCl Sales by Country (2021-2026) & (Units) Table 55. Europe Sertraline HCl Sales by Country (2027-2032) & (Units) Table 56. Asia Pacific Sertraline HCl Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Asia Pacific Sertraline HCl Sales by Country (2021-2026) & (Units) Table 58. Asia Pacific Sertraline HCl Sales by Country (2027-2032) & (Units) Table 59. South America, Middle East and Africa Sertraline HCl Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 60. South America, Middle East and Africa Sertraline HCl Sales by Country (2021-2026) & (Units) Table 61. South America, Middle East and Africa Sertraline HCl Sales by Country (2027-2032) & (Units) Table 62. Global Sertraline HCl Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Sertraline HCl Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Sertraline HCl Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Sertraline HCl Revenue Market Share by Region (2021-2026) Table 66. Global Sertraline HCl Revenue Market Share by Region (2027-2032) Table 67. Teva Company Information Table 68. Teva Business Overview Table 69. Teva Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Teva Sertraline HCl Product Portfolio Table 71. Teva Recent Development Table 72. Sun Pharmaceutical Company Information Table 73. Sun Pharmaceutical Business Overview Table 74. Sun Pharmaceutical Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sun Pharmaceutical Sertraline HCl Product Portfolio Table 76. Sun Pharmaceutical Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Novartis Sertraline HCl Product Portfolio Table 81. Novartis Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mylan Sertraline HCl Product Portfolio Table 86. Mylan Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pfizer Sertraline HCl Product Portfolio Table 91. Pfizer Recent Development Table 92. Wockhardt Company Information Table 93. Wockhardt Business Overview Table 94. Wockhardt Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Wockhardt Sertraline HCl Product Portfolio Table 96. Wockhardt Recent Development Table 97. Unimarck Pharma India Pvt Ltd Company Information Table 98. Unimarck Pharma India Pvt Ltd Business Overview Table 99. Unimarck Pharma India Pvt Ltd Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Unimarck Pharma India Pvt Ltd Sertraline HCl Product Portfolio Table 101. Unimarck Pharma India Pvt Ltd Recent Development Table 102. Torrent Pharma Company Information Table 103. Torrent Pharma Business Overview Table 104. Torrent Pharma Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Torrent Pharma Sertraline HCl Product Portfolio Table 106. Torrent Pharma Recent Development Table 107. Tanabe Mitsubishi Pharma Company Information Table 108. Tanabe Mitsubishi Pharma Business Overview Table 109. Tanabe Mitsubishi Pharma Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Tanabe Mitsubishi Pharma Sertraline HCl Product Portfolio Table 111. Tanabe Mitsubishi Pharma Recent Development Table 112. Lupin Company Information Table 113. Lupin Business Overview Table 114. Lupin Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Lupin Sertraline HCl Product Portfolio Table 116. Lupin Recent Development Table 117. Jing Xin Pharm Company Information Table 118. Jing Xin Pharm Business Overview Table 119. Jing Xin Pharm Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Jing Xin Pharm Sertraline HCl Product Portfolio Table 121. Jing Xin Pharm Recent Development Table 122. InvaGen Company Information Table 123. InvaGen Business Overview Table 124. InvaGen Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. InvaGen Sertraline HCl Product Portfolio Table 126. InvaGen Recent Development Table 127. Genericon Pharma Company Information Table 128. Genericon Pharma Business Overview Table 129. Genericon Pharma Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Genericon Pharma Sertraline HCl Product Portfolio Table 131. Genericon Pharma Recent Development Table 132. G.L. Pharma Company Information Table 133. G.L. Pharma Business Overview Table 134. G.L. Pharma Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. G.L. Pharma Sertraline HCl Product Portfolio Table 136. G.L. Pharma Recent Development Table 137. Daiichi-Sankyo Company Information Table 138. Daiichi-Sankyo Business Overview Table 139. Daiichi-Sankyo Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Daiichi-Sankyo Sertraline HCl Product Portfolio Table 141. Daiichi-Sankyo Recent Development Table 142. Aurobindo Pharma USA Company Information Table 143. Aurobindo Pharma USA Business Overview Table 144. Aurobindo Pharma USA Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Aurobindo Pharma USA Sertraline HCl Product Portfolio Table 146. Aurobindo Pharma USA Recent Development Table 147. Apotex Company Information Table 148. Apotex Business Overview Table 149. Apotex Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Apotex Sertraline HCl Product Portfolio Table 151. Apotex Recent Development Table 152. Alpic Biotech Company Information Table 153. Alpic Biotech Business Overview Table 154. Alpic Biotech Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Alpic Biotech Sertraline HCl Product Portfolio Table 156. Alpic Biotech Recent Development Table 157. Accord Healthcare Company Information Table 158. Accord Healthcare Business Overview Table 159. Accord Healthcare Sertraline HCl Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Accord Healthcare Sertraline HCl Product Portfolio Table 161. Accord Healthcare Recent Development Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Sertraline HCl Distributors List Table 165. Sertraline HCl Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Sertraline HCl Product Image Figure 2. Global Sertraline HCl Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sertraline HCl Market Size (2021-2032) & (US$ Million) Figure 4. Global Sertraline HCl Sales (2021-2032) & (Units) Figure 5. Global Sertraline HCl Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sertraline HCl Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 20 mg Image Figure 9. 25 mg Image Figure 10. 50 mg Image Figure 11. 100 mg Image Figure 12. Global Sertraline HCl Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Sertraline HCl Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Sertraline HCl Sales Market Share by Type (2021-2032) Figure 15. Global Sertraline HCl Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 16. Global Sertraline HCl Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Sertraline HCl Revenue Market Share by Type (2021-2032) Figure 18. OCD Image Figure 19. Premenstrual Anxiety Disorder Image Figure 20. Panic Disorder Image Figure 21. Depression Image Figure 22. Other Indications Image Figure 23. Global Sertraline HCl Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Sertraline HCl Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Sertraline HCl Sales Market Share by Application (2021-2032) Figure 26. Global Sertraline HCl Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 27. Global Sertraline HCl Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Sertraline HCl Revenue Market Share by Application (2021-2032) Figure 29. North America Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 30. North America Sertraline HCl Sales Market Share by Country (2021-2032) Figure 31. U.S. Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 32. Canada Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 33. Mexico Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 34. Europe Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 35. Europe Sertraline HCl Sales Market Share by Country (2021-2032) Figure 36. Germany Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 37. France Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 38. U.K. Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 39. Italy Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 40. Netherlands Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 41. Asia Pacific Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 42. Asia Pacific Sertraline HCl Sales Market Share by Country (2021-2032) Figure 43. China Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 44. Japan Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 45. South Korea Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 46. Southeast Asia Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 47. India Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 48. Australia Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 49. South America, Middle East and Africa Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 50. South America, Middle East and Africa Sertraline HCl Sales Market Share by Country (2021-2032) Figure 51. Brazil Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 52. South Africa Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 53. Saudi Arabia Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 54. Turkey Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 55. Argentina Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 56. UAE Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 57. Egypt Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 58. Chile Sertraline HCl Sales and Growth Rate (2021-2032) & (Units) Figure 59. Global Sertraline HCl Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Sertraline HCl Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Sertraline HCl Revenue (2021-2032) & (US$ Million) Figure 62. North America Sertraline HCl Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Sertraline HCl Revenue (2021-2032) & (US$ Million) Figure 64. Europe Sertraline HCl Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Sertraline HCl Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Sertraline HCl Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Sertraline HCl Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Sertraline HCl Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Sertraline HCl Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Sertraline HCl Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 20 mg
  • 25 mg
  • 50 mg
  • 100 mg
Applications
  • OCD
  • Premenstrual Anxiety Disorder
  • Panic Disorder
  • Depression
  • Other Indications
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Novartis
  • Mylan
  • Pfizer
  • Wockhardt
  • Unimarck Pharma India Pvt Ltd
  • Torrent Pharma
  • Tanabe Mitsubishi Pharma
  • Lupin
  • Jing Xin Pharm
  • InvaGen
  • Genericon Pharma
  • G.L. Pharma
  • Daiichi-Sankyo
  • Aurobindo Pharma USA
  • Apotex
  • Alpic Biotech
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sertraline HCl Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sertraline HCl Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sertraline HCl Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sertraline HCl Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sertraline HCl Market Dynamics
  1. 2.1 Sertraline HCl Industry Trends
  2. 2.2 Sertraline HCl Industry Drivers
  3. 2.3 Sertraline HCl Industry Opportunities and Challenges
  4. 2.4 Sertraline HCl Industry Restraints
3 Sertraline HCl Market by Manufacturers
  1. 3.1 Global Sertraline HCl Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sertraline HCl Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sertraline HCl Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sertraline HCl Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sertraline HCl Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sertraline HCl Manufacturers, Product Type & Application
  7. 3.7 Global Sertraline HCl Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sertraline HCl Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sertraline HCl Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sertraline HCl Tier 1, Tier 2, and Tier 3
4 Sertraline HCl Market by Type
  1. 4.1 Sertraline HCl Type Introduction
  2. 4.1.1 20 mg
  3. 4.1.2 25 mg
  4. 4.1.3 50 mg
  5. 4.1.4 100 mg
  6. 4.2 Global Sertraline HCl Sales by Type
  7. 4.2.1 Global Sertraline HCl Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sertraline HCl Sales by Type (2021-2032)
  9. 4.2.3 Global Sertraline HCl Sales Market Share by Type (2021-2032)
  10. 4.3 Global Sertraline HCl Revenue by Type
  11. 4.3.1 Global Sertraline HCl Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sertraline HCl Revenue by Type (2021-2032)
  13. 4.3.3 Global Sertraline HCl Revenue Market Share by Type (2021-2032)
5 Sertraline HCl Market by Application
  1. 5.1 Sertraline HCl Application Introduction
  2. 5.1.1 OCD
  3. 5.1.2 Premenstrual Anxiety Disorder
  4. 5.1.3 Panic Disorder
  5. 5.1.4 Depression
  6. 5.1.5 Other Indications
  7. 5.2 Global Sertraline HCl Sales by Application
  8. 5.2.1 Global Sertraline HCl Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Sertraline HCl Sales by Application (2021-2032)
  10. 5.2.3 Global Sertraline HCl Sales Market Share by Application (2021-2032)
  11. 5.3 Global Sertraline HCl Revenue by Application
  12. 5.3.1 Global Sertraline HCl Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Sertraline HCl Revenue by Application (2021-2032)
  14. 5.3.3 Global Sertraline HCl Revenue Market Share by Application (2021-2032)
6 Global Sertraline HCl Sales by Region
  1. 6.1 Global Sertraline HCl Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sertraline HCl Sales by Region (2021-2032)
  3. 6.2.1 Global Sertraline HCl Sales by Region (2021-2026)
  4. 6.2.2 Global Sertraline HCl Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sertraline HCl Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sertraline HCl Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sertraline HCl Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sertraline HCl Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sertraline HCl Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sertraline HCl Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sertraline HCl Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sertraline HCl Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sertraline HCl Revenue by Region
  1. 7.1 Global Sertraline HCl Revenue by Region
  2. 7.1.1 Global Sertraline HCl Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sertraline HCl Revenue by Region (2021-2026)
  4. 7.1.3 Global Sertraline HCl Revenue by Region (2027-2032)
  5. 7.1.4 Global Sertraline HCl Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sertraline HCl Revenue (2021-2032)
  8. 7.2.2 North America Sertraline HCl Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sertraline HCl Revenue (2021-2032)
  11. 7.3.2 Europe Sertraline HCl Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sertraline HCl Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sertraline HCl Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sertraline HCl Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sertraline HCl Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Sertraline HCl Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Sertraline HCl Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Sertraline HCl Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Sertraline HCl Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Sertraline HCl Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Wockhardt
  32. 8.6.1 Wockhardt Company Information
  33. 8.6.2 Wockhardt Business Overview
  34. 8.6.3 Wockhardt Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Wockhardt Sertraline HCl Product Portfolio
  36. 8.6.5 Wockhardt Recent Developments
  37. 8.7 Unimarck Pharma India Pvt Ltd
  38. 8.7.1 Unimarck Pharma India Pvt Ltd Company Information
  39. 8.7.2 Unimarck Pharma India Pvt Ltd Business Overview
  40. 8.7.3 Unimarck Pharma India Pvt Ltd Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Unimarck Pharma India Pvt Ltd Sertraline HCl Product Portfolio
  42. 8.7.5 Unimarck Pharma India Pvt Ltd Recent Developments
  43. 8.8 Torrent Pharma
  44. 8.8.1 Torrent Pharma Company Information
  45. 8.8.2 Torrent Pharma Business Overview
  46. 8.8.3 Torrent Pharma Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Torrent Pharma Sertraline HCl Product Portfolio
  48. 8.8.5 Torrent Pharma Recent Developments
  49. 8.9 Tanabe Mitsubishi Pharma
  50. 8.9.1 Tanabe Mitsubishi Pharma Company Information
  51. 8.9.2 Tanabe Mitsubishi Pharma Business Overview
  52. 8.9.3 Tanabe Mitsubishi Pharma Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tanabe Mitsubishi Pharma Sertraline HCl Product Portfolio
  54. 8.9.5 Tanabe Mitsubishi Pharma Recent Developments
  55. 8.10 Lupin
  56. 8.10.1 Lupin Company Information
  57. 8.10.2 Lupin Business Overview
  58. 8.10.3 Lupin Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lupin Sertraline HCl Product Portfolio
  60. 8.10.5 Lupin Recent Developments
  61. 8.11 Jing Xin Pharm
  62. 8.11.1 Jing Xin Pharm Company Information
  63. 8.11.2 Jing Xin Pharm Business Overview
  64. 8.11.3 Jing Xin Pharm Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jing Xin Pharm Sertraline HCl Product Portfolio
  66. 8.11.5 Jing Xin Pharm Recent Developments
  67. 8.12 InvaGen
  68. 8.12.1 InvaGen Company Information
  69. 8.12.2 InvaGen Business Overview
  70. 8.12.3 InvaGen Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 InvaGen Sertraline HCl Product Portfolio
  72. 8.12.5 InvaGen Recent Developments
  73. 8.13 Genericon Pharma
  74. 8.13.1 Genericon Pharma Company Information
  75. 8.13.2 Genericon Pharma Business Overview
  76. 8.13.3 Genericon Pharma Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Genericon Pharma Sertraline HCl Product Portfolio
  78. 8.13.5 Genericon Pharma Recent Developments
  79. 8.14 G.L. Pharma
  80. 8.14.1 G.L. Pharma Company Information
  81. 8.14.2 G.L. Pharma Business Overview
  82. 8.14.3 G.L. Pharma Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 G.L. Pharma Sertraline HCl Product Portfolio
  84. 8.14.5 G.L. Pharma Recent Developments
  85. 8.15 Daiichi-Sankyo
  86. 8.15.1 Daiichi-Sankyo Company Information
  87. 8.15.2 Daiichi-Sankyo Business Overview
  88. 8.15.3 Daiichi-Sankyo Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Daiichi-Sankyo Sertraline HCl Product Portfolio
  90. 8.15.5 Daiichi-Sankyo Recent Developments
  91. 8.16 Aurobindo Pharma USA
  92. 8.16.1 Aurobindo Pharma USA Company Information
  93. 8.16.2 Aurobindo Pharma USA Business Overview
  94. 8.16.3 Aurobindo Pharma USA Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aurobindo Pharma USA Sertraline HCl Product Portfolio
  96. 8.16.5 Aurobindo Pharma USA Recent Developments
  97. 8.17 Apotex
  98. 8.17.1 Apotex Company Information
  99. 8.17.2 Apotex Business Overview
  100. 8.17.3 Apotex Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Apotex Sertraline HCl Product Portfolio
  102. 8.17.5 Apotex Recent Developments
  103. 8.18 Alpic Biotech
  104. 8.18.1 Alpic Biotech Company Information
  105. 8.18.2 Alpic Biotech Business Overview
  106. 8.18.3 Alpic Biotech Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Alpic Biotech Sertraline HCl Product Portfolio
  108. 8.18.5 Alpic Biotech Recent Developments
  109. 8.19 Accord Healthcare
  110. 8.19.1 Accord Healthcare Company Information
  111. 8.19.2 Accord Healthcare Business Overview
  112. 8.19.3 Accord Healthcare Sertraline HCl Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Accord Healthcare Sertraline HCl Product Portfolio
  114. 8.19.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sertraline HCl Value Chain Analysis
  2. 9.1.1 Sertraline HCl Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sertraline HCl Production Mode & Process
  6. 9.2 Sertraline HCl Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sertraline HCl Distributors
  9. 9.2.3 Sertraline HCl Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst